Insulin drops vs amniotic membrane for stubborn corneal sores
Part of Eyes & vision clinical trials.
This trial compares two treatments for persistent corneal surface wounds that haven't healed with standard care. You'll receive either insulin eye drops or a special tissue graft to help your cornea heal.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a corneal epithelial defect (a sore on the clear front of your eye) that has not improved after 2 or more weeks of standard treatment
- You do not have uncontrolled diabetes or other systemic autoimmune conditions
- You have not had eye surgery in the past 3 months
- You do not have a hereditary corneal disease (an inherited eye condition affecting your cornea)
- You do not currently have an active infection in your eye
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special substance from stem cells (called secretome) can help heal chronic surface problems on the eye that haven't gotten better with standard treatments. It's for people with a stubborn scratch or defect on the cornea that has lasted more than 14 days.
This study tests whether cenegermin eye drops help heal stubborn corneal ulcers (open sores on the clear front of the eye) that haven't improved with standard treatments like lubricating drops or contact lenses.
This Phase 2 trial tests whether a treatment gel called NEXAGON (lufepirsen) can improve healing and safety in people with a persistent corneal problem called PCED that hasn’t gotten better despite standard non-surgical treatments. You may be a candidate if your defect has lasted at least 2 weeks and hasn’t improved recently, and if you don’t have certain eye infections or other eye conditions.
This trial tests whether insulin eye drops can help the cornea heal faster after corneal crosslinking, a procedure to treat keratoconus. It is for people with keratoconus who do not have diabetes, severe dry eye, or certain other eye conditions.
This Phase 2 trial tests a locally delivered cell-based treatment (allogeneic mesenchymal stromal cells) to help heal long-lasting damage to the eye’s clear surface (the cornea). It may help if your cornea epithelium (surface layer) won’t improve even after standard non-surgical treatments.
This trial tests whether a special insulin eye drop can help heal the clear front part of your eye (cornea) faster after PRK laser vision correction. If you are having PRK for nearsightedness or astigmatism and have no other eye problems or conditions like diabetes, you may be able to join.
Hear when a new Persistent Corneal Epithelial Defect trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.